Pulmonx Corp

LUNGNASDAQ · USD
2.07USD0.00 (+4.55%)
6510

Pulmonx Corp (LUNG) Wheel Strategy

No qualifying wheel strategy setups were found for LUNG in the prior session.

Read more

Running a LUNG wheel strategy lets you generate consistent premium income on Pulmonx Corp while setting your own entry and exit prices on the underlying. Pulmonx Corp's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own LUNG, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best LUNG wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on LUNG, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable LUNG wheel from a losing one.

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves.

It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the LUNG wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your LUNG wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

No illustrative rows to display.

As of September 18, 2026

Run the Wheel on LUNG With Confidence

Find the best LUNG wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial